EVEREST II
Showing 9976 - 10000 of >10,000
Colorectal Cancer Trial in Guangzhou (JS001, regorafenib tablet)
Unknown status
- Colorectal Cancer
- JS001
- regorafenib tablet
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 11, 2020
Mild Cognitive Impairment Trial in Hong Kong (Stretching exercise, Low-frequency, moderate-intensity walking group,
Completed
- Mild Cognitive Impairment
- Stretching exercise
- +4 more
-
Hong Kong, Southern District, Hong KongLi Kai Shing Faculty of Medicine
Nov 10, 2021
Prostate Cancer Trial in Canada (sorafenib tosylate)
Completed
- Prostate Cancer
- sorafenib tosylate
-
Calgary, Alberta, Canada
- +6 more
Apr 7, 2020
Distal Hypospadias Trial in New Delhi (Ropivacaine, Fentanyl Citrate)
Completed
- Distal Hypospadias
- Ropivacaine
- Fentanyl Citrate
-
New Delhi, Delhi, IndiaSir Ganga Ram Hospital
Oct 29, 2020
Acute Myelogenous Leukemia Trial in Chicago, Minneapolis, Columbus (Interventions)
Terminated
- Acute Myelogenous Leukemia
- Interventions
-
Chicago, Illinois
- +2 more
Jul 8, 2020
Primary CNS Non-Hodgkin Lymphoma Trial in Cleveland (rituximab, yttrium Y 90 ibritumomab tiuxetan)
Terminated
- Primary Central Nervous System Non-Hodgkin Lymphoma
- rituximab
- yttrium Y 90 ibritumomab tiuxetan
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 23, 2020
HIV, ART Trial in Sweetwaters, Kabwohe (ART initiation in the home, Mobile Van Refill and Monitoring, Clinic ART Initiation)
Completed
- HIV
- ART
- ART initiation in the home
- +3 more
-
Sweetwaters, Kwa-Zulu Natal, South Africa
- +1 more
Oct 27, 2020
Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in
Completed
- Gastrin-Producing Neuroendocrine Tumor
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Boston, Massachusetts
- +2 more
Mar 25, 2020
Hydroxychloroquine, BRAF and MEK Inhibitors in Metastatic
Completed
- Dermatology and Oncology
- pre-treatment data
- during study treatment
-
Pierre-BĂ©nite, FranceCentre Hospitalier Lyon Sud
Feb 16, 2021
Covid19 Trial in Conakry (Hydroxycloroquine and Azythromycine, Cospherunate/Azythromycine,
Unknown status
- Covid19
- Hydroxycloroquine and Azythromycine
- +2 more
-
Conakry, GuineaDonka; Kenien; Gbessia
Aug 5, 2020
Biliary Tract Tumors Trial in Taipei (Tegafur, Leucovorin, Oxaliplatin)
Recruiting
- Biliary Tract Neoplasms
- Tegafur
- +4 more
-
Taipei, TaiwanTaiwan Cooperative Oncology Group, National Health Research Inst
Sep 15, 2020
Prostate Tumors, Toxicity Due to Radiotherapy Trial in Tampere (Fractionation, hypofractionated, stereotactic fractionation)
Completed
- Prostate Neoplasms
- Toxicity Due to Radiotherapy
- Fractionation
- +2 more
-
Tampere, FinlandTampere University Hospital
Oct 26, 2020
Type II Diabetes Trial in Lisieux (PAZ320, Placebo)
Withdrawn
- Type II Diabetes
- PAZ320
- Placebo
-
Lisieux, Normandy, FranceDepartment of Internal Medicine, Infectious Diseases and Diabeto
Sep 24, 2020
Acute Graft-versus-host Disease Trial in Japan (Itacitinib, Corticosteroid)
Completed
- Acute Graft-versus-host Disease
-
Anjo-Shi, Aichi, Japan
- +16 more
Mar 2, 2020
Eus-giuded Biliary Drainage With Ec-lams vs ERCP asPrimary
Recruiting
- DISTAL MALIGNANT BILIARY OBSTRUCTION
- ERCP
- EUS-BD
-
Rozzano, Milano, ItalyEndoscopy Unit, Humanitas Research Hospital
Sep 14, 2021
Liver Tumors Trial in Belgium, France, Netherlands (Radiation therapy, chemoembolization)
Terminated
- Liver Neoplasms
- Radiation therapy
- chemoembolization
-
Antwerp, Belgium
- +10 more
Jan 25, 2021
Lung Carcinoma, Malignant Respiratory Tract Tumor, Metastatic Malignant Tumor in the Lung Trial in Houston (device, procedure,
Recruiting
- Lung Carcinoma
- +2 more
- Biphasic Positive Airway Pressure
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Aug 5, 2020
CD19 Negative B-cell Malignancies Trial in Shenzhen, Shijiazhuang (Infusion of 4SCAR-T specific to CD22/CD123/CD38/ CD10/CD20)
Recruiting
- CD19 Negative B-cell Malignancies
- Infusion of 4SCAR-T specific to CD22/CD123/CD38/ CD10/CD20
-
Shenzhen, Guangdong, China
- +2 more
Jun 10, 2020
Sickle Cell Disease, Stroke Trial in Kaduna, Kano (Hydroxyurea (Moderate Dose), Hydroxyurea (Low Dose))
Completed
- Sickle Cell Disease
- Stroke
- Hydroxyurea (Moderate Dose)
- Hydroxyurea (Low Dose)
-
Kaduna, Nigeria
- +2 more
Jul 31, 2020
Healthy Volunteers Trial in Beijing (Meloxicam)
Unknown status
- Healthy Volunteers
-
Beijing, Beijing, ChinaInstitution of Drug Clinical Trials
Apr 26, 2020